BX4-28793-45839
4 vaccinations
6 coded responses
32 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 604 / IL
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Survey response — day 0, dose 1MedDRA: Injection site pain, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: The mildest of soreness at the injection site, similar to a flu shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 1MedDRA: Injection site discomfort, Tenderness — Feeling: GoodFree text: Tenderness to touch/pressure at injection site, slightly worse than yesterday. Similar to sore muscle following a good workout.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Soreness at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Very minor soreness at injection site. Less than previous day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: The most mild of soreness at injection site; almost gone.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
-
2021-04-08
Survey response — day 0, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: The mild of soreness at injection site, as one might expect from a needle.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
- 2021-10-08
-
2021-10-24
Dose 3 — Pfizer-BioNTech
- 2022-04-09
-
2022-10-03
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-16
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-16
- 2023-01-02
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-10-24 | Pfizer-BioNTech | No |
| 4 | 2022-10-03 | Pfizer-BioNTech | Flu |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): The mildest of soreness at the injection site, similar to a flu shot.
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Tenderness to touch/pressure at injection site, slightly worse than yesterday. Similar to sore muscle following a good workout.
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Soreness at injection site.
Systemic reaction (other): Very minor soreness at injection site. Less than previous day.
Systemic reaction (other): The most mild of soreness at injection site; almost gone.
Release 7 — day 0, dose 2
Systemic reaction (other): The mild of soreness at injection site, as one might expect from a needle.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release